Analyst Ratings February 13, 2026

Guggenheim Lifts Sphere Entertainment Target After Strong Quarterly Results

Firm raises price target to $150 and keeps Buy as Q4 results and company drivers outpace expectations

By Priya Menon SPHR
Guggenheim Lifts Sphere Entertainment Target After Strong Quarterly Results
SPHR

Guggenheim boosted its price target for Sphere Entertainment (SPHR) to $150 from $136 and retained a Buy rating after the company reported stronger-than-expected fourth-quarter results. Sphere’s segment revenue and adjusted operating income surpassed Guggenheim’s estimates, driven in part by the performance of the "The Wizard of Oz" experience. The research house also raised near-term AOI forecasts and projected continued year-over-year growth backed by events, sponsorships and venue utilization.

Key Points

  • Guggenheim raised its price target on Sphere Entertainment to $150 from $136 and maintained a Buy rating after the company’s Q4 results exceeded estimates.
  • Sphere’s Q4 segment revenue of $274 million and AOI of $89 million outpaced Guggenheim’s previous expectations, with the "The Wizard of Oz" experience singled out as a material contributor.
  • Guggenheim lifted its 2026 AOI forecast to $235 million and expects Q1 revenue of $246 million and AOI of $53 million, citing show scaling, venue utilization, and growth in sponsorship and advertising as key drivers; sectors impacted include live entertainment, venues, and advertising/sponsorship markets.

Guggenheim increased its price target for Sphere Entertainment (NYSE:SPHR) to $150.00 from $136.00 on Friday, while leaving its rating at Buy. The move follows the company’s fourth-quarter financial disclosures, which yielded results that topped the research firm’s expectations.

At the time of the update, shares of SPHR were trading at $111.98. The stock has exhibited notable momentum over the past year, delivering a 144% gain and trading close to a 52-week high of $117.06.

Guggenheim’s decision to raise the target was informed by the Sphere segment’s Q4 performance. The segment reported revenue of $274 million and adjusted operating income, or AOI, of $89 million. Those figures exceeded Guggenheim’s prior estimates of $255 million in revenue and $75 million in AOI.

The firm attributed part of the upside to stronger-than-expected results from the "The Wizard of Oz" experience during the quarter, noting that the attraction outperformed even Guggenheim’s earlier upward revisions.

Looking ahead, Guggenheim set out a first-quarter forecast that calls for $246 million in revenue and $53 million in AOI for the Sphere segment. The research firm characterized the outlook as implying meaningful year-over-year growth, driven by continued momentum from the "The Wizard of Oz" experience, an active concert and event schedule, and new sponsorship agreements.

Guggenheim also raised its full-year 2026 AOI forecast to $235 million from $220 million. The firm cited expectations that financial results will continue to improve as shows and residencies scale, venue utilization increases, cost discipline holds, and advertising, sponsorship and suite revenue grow.

Separately, Sphere Entertainment Co. reported Q4 2025 GAAP results that significantly surprised the market to the upside. The company posted earnings per share of $1.23, compared with an anticipated EPS of -$0.30, representing a 510% surprise versus expectations. On the top line, reported revenue for the quarter was $394.3 million versus an expected $372.92 million, a 5.73% surprise.

Those quarterly results and the subsequent analyst attention have heightened investor focus on the company’s near-term trajectory. The earnings beat and revenue outperformance are central elements cited by Guggenheim in its forecast revisions and target increase.


Outlook and implications

Guggenheim’s updated forecasts and price-target lift reflect the firm’s view that Sphere’s operating performance and revenue mix can continue to improve as events and sponsorships expand. The research house points to scaled shows and residencies, higher venue utilization and growth in advertising, sponsorship and suite sales as primary levers for AOI expansion.

Market reaction to the results has appeared positive, with the stock trading well above pre-report levels and near its annual highs.


Limitations

The company’s near-term projections and Guggenheim’s forecasts are tied to the ongoing success of specific experiences, event scheduling and sponsorship deals that underpinned the recent quarter’s outperformance.


Key financials cited

  • Q4 Sphere segment revenue: $274 million
  • Q4 Sphere segment AOI: $89 million
  • Guggenheim Q4 estimates (prior): $255 million revenue, $75 million AOI
  • Guggenheim Q1 forecast: $246 million revenue, $53 million AOI
  • Guggenheim 2026 AOI forecast: $235 million (up from $220 million)
  • Reported Q4 2025 EPS: $1.23 vs expected -$0.30 (510% surprise)
  • Reported Q4 2025 revenue: $394.3 million vs expected $372.92 million (5.73% surprise)

Risks

  • Forecasts depend on continued strong performance from specific attractions and events such as the "The Wizard of Oz" experience; failure to sustain that demand could affect revenue and AOI - this impacts the live entertainment and venue utilization sectors.
  • Projected financial improvement relies on scaling shows and residencies, higher venue utilization and growth in sponsorship and suite revenue; execution risks or weaker-than-expected sponsorship demand could limit upside - this affects advertising and sponsorship markets as well as venue operations.
  • Near-term guidance and analyst expectations are sensitive to the company’s concert and event lineup; changes to scheduling or lower attendance would present uncertainty for revenue projections and operating income.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026